DWM Medical is Taiwan’s first medical device platform company centered on locally sourced corn-based polymers, vertically integrating raw material synthesis, polymer microsphere R&D, mass production, and aesthetic clinical applications. The company has developed proprietary eggshell-structured polymer microspheres to systematically address safety concerns such as embolism and nodules in regenerative medical devices at the material level. It is also building a global patent portfolio to establish a strong technological moat. In addition, DWM Medical is Taiwan’s first provider of mechanical needle-free drug delivery solutions, leveraging a dual platform of materials and delivery systems to enable standardized and scalable business models.